Tianma modulates blood vessel tonicity

Open Biochemistry Journal

Volumn 6, Issue , 2012, Pages 56-65

  Feng, Lin ^a,d   Manavalan, Arulmani ^a,b   Mishra, Manisha ^a,b   Sze, Siu Kwan ^a   Hu, Jiang Miao ^c   Heese, Klaus ^a,b  

^a NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^b NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^c KUNMING INSTITUTE OF BOTANY   (China)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aorta; TCM; Tianma; Vascular disease

Indexed keywords

ACETYLCHOLINE; ACTIN; CHINESE DRUG; DESMIN; FIBULIN 5; LIPOCORTIN 2; PHENYLEPHRINE; POTASSIUM CHLORIDE; TIANMA; UNCLASSIFIED DRUG; VASODILATOR AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY COMPLIANCE; ARTERY CONSTRICTION; ARTERY ENDOTHELIUM; ARTICLE; BLOOD VESSEL TONE; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DOWN REGULATION; GASTRODIA ELATA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN METABOLISM; RAT; RHIZOME; THORACIC AORTA; UPREGULATION; VASCULAR SMOOTH MUSCLE; VASODILATATION;

EID: 84863787837     PISSN: None     EISSN: 1874091X     Source Type: Journal    
DOI: 10.2174/1874091X01206010056     Document Type: Article

References (73)

1. Rates, S. M. Plants as source of drugs. Toxicon, 2001, 39(5), 603-613.
2. Rishton, G. M. Natural products as a robust source of new drugs and drug leads: past successes and present day issues. Am. J. Cardiol., 2008, 101(10A), 43D-49D.
3. Butler, A. R. Traditional Chinese herbal medicine. Rep. Proc. Scott. Soc. Hist. Med., 1992, (93-94), 16-18.
4. Ojemann, L. M.; Nelson, W. L.; Shin, D. S.; Buchanan, R. A. Tianma, an ancient Chinese herb, offers new options for the treatment of epilepsy and other conditions. Epilepsy Behav., 2006, 8(2), 376-383.
5. Bulpitt, C. J.; Li, Y.; Bulpitt, P. F.; Wang, J. The use of orchids in Chinese medicine. J. R. Soc. Med., 2007, 100(12), 558-563.
6. Hew, C. S.; Yong, J. W. H. Orchids in Chinese medicine. Innovation, 2007, 6, 2-4.
7. Xu, J.; Guo, S. Retrospect on the research of the cultivation of Gastrodia elata Bl, a rare traditional Chinese medicine. Chin. Med. J. 2000, 113(8), 686-692.
8. Baek, N. I.; Choi, S. Y.; Park, J. K.; Cho, S. W.; Ahn, E. M.; Jeon, S. G.; Lee, B. R.; Bahn, J. H.; Kim, Y. K.; Shon, I. H. Isolation and identification of succinic semialdehyde dehydrogenase inhibitory compound from the rhizome of Gastrodia elata Blume. Arch. Pharm. Res., 1999, 22(2), 219-224.
9. Xiao, Y. Q.; Li, L.; You, X. L. Studies on chemical constituents of effective part of Gastrodia elata. Zhongguo Zhong Yao Za Zhi, 2002, 27(1), 35-36.
10. Ong, E. S.; Heng, M. Y.; Tan, S. N.; Hong Yong, J. W.; Koh, H.; Teo, C. C.; Hew, C. S. Determination of gastrodin and vanillyl alcohol in Gastrodia elata Blume by pressurized liquid extraction at room temperature. J. Sep. Sci., 2007, 30(13), 2130-2137.
11. Teo, C. C.; Tan, S. N.; Yong, J. W.; Hew, C. S.; Ong, E. S. Evaluation of the extraction efficiency of thermally labile bioactive compounds in Gastrodia elata Blume by pressurized hot water extraction and microwave-assisted extraction. J. Chromatogr. A, 2008, 1182(1), 34-40.
12. Mishra, M.; Huang, J.; Lee, Y. Y.; Chua, D. S.; Lin, X.; Hu, J. M.; Heese, K. Gastrodia elata modulates amyloid precursor protein cleavage and cognitive functions in mice. Biosci. Trends, 2011, 5(3), 129-138.
13. Pyo, M. K.; Jin, J. L.; Koo, Y. K.; Yun-Choi, H. S. Phenolic and furan type compounds isolated from Gastrodia elata and their anti-platelet effects. Arch. Pharm. Res., 2004, 27(4), 381-385.
14. Buemi, M.; Corica, F.; Marino, D.; Medici, M. A.; Aloisi, C.; Di Pasquale, G.; Ruello, A.; Sturiale, A.; Senatore, M.; Frisina, N. Cardiovascular remodeling, apoptosis, and drugs. Am. J. Hypertens., 2000, 13(4 Pt 1), 450-454.
15. Owens, G. K.; Kumar, M. S.; Wamhoff, B. R. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol. Rev., 2004, 84(3), 767-801.
16. Wang, S.; Chen, Y.; He, D.; He, L.; Yang, Y.; Chen, J.; Wang, X. Inhibition of vascular smooth muscle cell proliferation by serum from rats treated orally with Gastrodia and Uncaria decoction, a traditional Chinese formulation. J. Ethnopharmacol., 2007, 114(3), 458-462.
17. Hayashi, J.; Sekine, T.; Deguchi, S.; Lin, Q.; Horie, S.; Tsuchiya, S.; Yano, S.; Watanabe, K.; Ikegami, F. Phenolic compounds from Gastrodia rhizome and relaxant effects of related compounds on isolated smooth muscle preparation. Phytochemistry, 2002, 59(5), 513-519.
18. Teong, I. W. J.; Ko, A. A. R.; Li, M.; Heese, K.; Liang, W. Gastrodia elata decreases isoprenaline potency and enhances spontaneous phasic activity in the rat detrusor. Int. J. Physiol. Pathophysiol. Pharmacol., 2011, 3(1), 29-37.
19. Sundaramurthi, H.; Manavalan, A.; Ramachandran, U.; Sze, S. K.; Heese, K. Phenotyping of tianma-stimulated differentiated rat neuronal b104 cells by quantitative proteomics. Neurosignals, 2012, 20(1), 48-60.
20. Chen, P. J.; Hsieh, C. L.; Su, K. P.; Hou, Y. C.; Chiang, H. M.; Lin, I. H.; Sheen, L. Y. The antidepressant effect of Gastrodia elata. Bl. on the forced-swimming test in rats. Am. J. Chin. Med., 2008, 36(1), 95-106.
21. Brundin, P.; Li, J. Y. Holton, J. L. Lindvall, O.; Revesz, T. Research in motion: the enigma of Parkinson's disease pathology spread. Nat. Rev. Neurosci. 2008, 9(10), 741-745.
22. Ho, S. C.; Ho, Y. F.; Lai, T. H.; Liu, T. H.; Wu, R. Y. Traditional Chinese herbs against hypertension enhance memory acquisition. Am. J. Chin. Med., 2005, 33(5), 787-795.
23. Zhang, G. M.; Yang, L. X. Research and Development of Zhaotong Tianma; Yunnan Science and Techonology Press: China, 2007; pp 86-91.
24. Li, N.; Wang, K. J.; Chen, J. J.; Zhou, J. Phenolic compounds from the rhizomes of Gastrodia elata. J. Asian Nat. Prod. Res., 2007, 9(3-5), 373-377.
25. Hsieh, C. L.; Lin, J. J.; Chiang, S. Y.; Su, S. Y.; Tang, N. Y.; Lin, G.G.; Lin, I. H.; Liu, C. H.; Hsiang, C. Y.; Chen, J. C.; Ho, T. Y. Gastrodia elata modulated activator protein 1 via c-Jun N-terminal kinase signaling pathway in kainic acid-induced epilepsy in rats. J. Ethnopharmacol., 2007, 109(2), 241-247.
26. Ho, S. C.; Ho, Y. F.; Lai, T. H.; Liu, T. H.; Su, S. Y.; Wu, R. Y. Effect of Tianma Gouteng Decoction with subtractive ingredients and its active constituents on memory acquisition. Am. J. Chin. Med., 2008, 36(3), 593-602.
27. Jang, Y. W.; Lee, J. Y.; Kim, C. J. Anti-asthmatic activity of phenolic compounds from the roots of Gastrodia elata Bl. Int. Immunopharmacol., 2010, 10(2), 147-154.
28. Osol, G.; Cipolla, M.; Knutson, S. A new method for mechanically denuding the endothelium of small (50-150 microns) arteries with a human hair. Blood Vessels, 1989, 26(5), 320-324.
29. Simonsen, U.; Garcia-Sacristan, A.; Prieto, D. Apamin-sensitive K+ channels involved in the inhibition of acetylcholine-induced contractions in lamb coronary small arteries. Eur. J. Pharmacol., 1997, 329(2-3), 153-163.
30. Mulvany, M. J.; Halpern, W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ. Res., 1977, 41(1), 19-26.
31. Datta, A.; Park, J. E.; Li, X.; Zhang, H.; Ho, Z. S.; Heese, K.; Lim, S. K.; Tam, J. P.; Sze, S. K. Phenotyping of an in vitro model of ischemic penumbra by iTRAQ-based shotgun quantitative proteomics. J. Proteome Res., 2010, 9(1), 472-484.
32. Datta, A.; Jingru, Q.; Khor, T. H.; Teo, M. T.; Heese, K.; Sze, S. K. Quantitative neuroproteomics of an in vivo rodent model of focal cerebral ischemia reperfusion injury reveals a temporal regulation of novel pathophysiological molecular markers. J. Proteome Res., 2011, 10(11), 5199-5213.
33. Mishra, M.; Manavalan, A.; Sze, S. K.; Heese, K. Neuronal p60TRP expression modulates cardiac capacity. J. Proteomics, 2012, 75(5), 1600-1617.
34. Islam, O.; Loo, T. X.; Heese, K. Brain-derived neurotrophic factor (BDNF) has proliferative effects on neural stem cells through the truncated TRK-B receptor, MAP kinase, AKT, and STAT-3 signaling pathways. Curr. Neurovasc. Res., 2009, 6(1), 42-53.
35. Shen, Y.; Inoue, N.; Heese, K. Neurotrophin-4 (ntf4) mediates neurogenesis in mouse embryonic neural stem cells through the inhibition of the signal transducer and activator of transcription-3 (stat3) and the modulation of the activity of protein kinase B. Cell Mol. Neurobiol., 2010, 30(6), 909-916.
36. Mishra, M.; Akatsu, H.; Heese, K. The novel protein MANI modulates neurogenesis and neurite-cone growth. J. Cell Mol. Med., 2011, 15(8), 1713-1725.
37. Hiller, K.; Schobert, M.; Hundertmark, C.; Jahn, D.; Munch, R. JVirGel: Calculation of virtual two-dimensional protein gels. Nucleic Acids Res., 2003, 31(13), 3862-3865.
38. Szklarczyk, D.; Franceschini, A.; Kuhn, M.; Simonovic, M.; Roth, A.; Minguez, P.; Doerks, T.; Stark, M.; Muller, J.; Bork, P.; Jensen, L. J.; von Mering, C. The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res., 2011, 39(Database issue), D561-D568.
39. Kolakowski, J.; Makuch, R.; Stepkowski, D.; Dabrowska, R. Interaction of calponin with actin and its functional implications. Biochem. J., 1995, 306 (Pt 1), 199-204.
40. Szymanski, P. T.; Tao, T. Interaction between calponin and smooth muscle myosin. FEBS Lett., 1993, 334(3), 379-382.
41. Pardo, J. V.; Siliciano, J. D.; Craig, S. W. Vinculin is a component of an extensive network of myofibril-sarcolemma attachment regions in cardiac muscle fibers. J. Cell Biol., 1983, 97(4), 1081-1088.
42. Craig, S. W.; Pardo, J. V. Gamma actin, spectrin, and intermediate filament proteins colocalize with vinculin at costameres, myofibril-to-sarcolemma attachment sites. Cell Motil., 1983, 3(5-6), 449-462.
43. Costa, M. L.; Escaleira, R.; Cataldo, A.; Oliveira, F.; Mermelstein, C. S. Desmin: molecular interactions and putative functions of the muscle intermediate filament protein. Braz. J. Med. Biol. Res., 2004, 37(12), 1819-1830.
44. Webb, R. C. Smooth muscle contraction and relaxation. Adv. Physiol. Educ., 2003, 27(1-4), 201-206.
45. Lazarides, E.; Hubbard, B. D. Immunological characterization of the subunit of the 100 A filaments from muscle cells. Proc., Natl. Acad. Sci., USA, 1976, 73(12), 4344-4348.
46. Hubbard, B. D.; Lazarides, E. Copurification of actin and desmin from chicken smooth muscle and their copolymerization in vitro to intermediate filaments. J. Cell Biol., 1979, 80(1), 166-1082.
47. Paulin, D.; Li, Z. Desmin: a major intermediate filament protein essential for the structural integrity and function of muscle. Exp. Cell Res., 2004, 301(1), 1-7.
48. Milner, D. J; Weitzer, G.; Tran, D.; Bradley, A.; Capetanaki, Y. Disruption of muscle architecture and myocardial degeneration in mice lacking desmin. J. Cell Biol., 1996, 134(5), 1255-1270.
49. Geiger, B.; Tokuyasu, K. T.; Dutton, A. H.; Singer, S. J. Vinculin, An intracellular protein localized at specialized sites where micro-filament bundles terminate at cell membranes. Proc. Natl. Acad. Sci. USA, 1980, 77(7), 4127-4131.
50. Evans, R. R.; Robson, R. M.; Stromer, M. H. Properties of smooth muscle vinculin. J. Biol., Chem., 1984, 259(6), 3916-3924.
51. Chinnakkannu, P.; Samanna, V.; Cheng, G.; Ablonczy, Z.; Baicu, C. F.; Bethard, J. R.; Menick, D. R.; Kuppuswamy, D.; Cooper, G. T. Site-specific microtubule-associated protein 4 dephosphorylation causes microtubule network densification in pressure overload cardiac hypertrophy. J. Biol. Chem., 2010, 285(28), 21837-21848.
52. Tamura, N.; Ohno, K.; Katayama, T.; Kanayama, N.; Sato, K. The PDZ-LIM protein CLP36 is required for actin stress fiber formation and focal adhesion assembly in BeWo cells. Biochem. Biophys. Res. Commun., 2007, 364(3), 589-594.
53. Makinen, T.; Adams, R. H.; Bailey, J.; Lu, Q.; Ziemiecki, A.; Alitalo, K.; Klein, R.; Wilkinson, G. A. PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature. Genes Dev., 2005, 19(3), 397-410.
54. Li, D.Y.; Brooke, B.; Davis, E. C.; Mecham, R. P.; Sorensen, L. K.; Boak, B. B.; Eichwald, E.; Keating, M. T. Elastin is an essential determinant of arterial morphogenesis. Nature, 1998, 393(6682), 276-280.
55. Karnik, S. K.; Brooke, B. S.; Bayes-Genis, A.; Sorensen, L.; Wythe, J. D.; Schwartz, R. S.; Keating, M. T.; Li, D. Y. A critical role for elastin signaling in vascular morphogenesis and disease. Development, 2003, 130(2), 411-423.
56. Argraves, W. S.; Tran, H.; Burgess, W. H.; Dickerson, K. Fibulin is an extracellular matrix and plasma glycoprotein with repeated domain structure. J. Cell Biol., 1990, 111(6 Pt 2), 3155-3164.
57. Bengtsson, E.; Morgelin, M.; Sasaki, T.; Timpl, R.; Heinegard, D.; Aspberg, A. The leucine-rich repeat protein PRELP binds perlecan and collagens and may function as a basement membrane anchor. J. Biol. Chem., 2002, 277(17), 15061-16068.
58. Conway, S. J.; Molkentin, J. D. Periostin as a heterofunctional regulator of cardiac development and disease. Curr. Genomics, 2008, 9(8), 548-555.
59. Liu, S.; Piatigorsky, J. Regulation of mouse small heat shock protein alphab-crystallin gene by aryl hydrocarbon receptor. PLoS ONE, 2011, 6(4), e17904.
60. Cesarman, G. M.; Guevara, C. A.; Hajjar, K. A. An endothelial cell receptor for plasminogen/tissue plasminogen activator (t-PA). II. Annexin II-mediated enhancement of t-PA-dependent plasminogen activation. J. Biol. Chem., 1994, 269(33), 21198-21203.
61. Hajjar, K. A.; Jacovina, A. T.; Chacko, J. An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. Identity with annexin II. J. Biol. Chem., 1994, 269(33), 21191-21197.
62. Dudani, A. K.; Pluskota, A.; Ganz, P. R. Interaction of tissue plasminogen activator with a human endothelial cell 45-kilodalton plasminogen receptor. Biochem. Cell Biol., 1994, 72(3-4), 126-131.
63. Flood, E. C.; Hajjar, K. A. The annexin A2 system and vascular homeostasis. Vascul. Pharmacol., 2011, 54(3-6), 59-67.
64. Suhre, K.; Romisch-Margl, W.; de Angelis, M. H.; Adamski, J.; Luippold, G.; Augustin, R. Identification of a potential biomarker for FABP4 inhibition: the power of lipidomics in preclinical drug testing. J. Biomol. Screen., 2011, 16(5), 467-475.
65. Ordovas, J. M. Identification of a functional polymorphism at the adipose fatty acid binding protein gene (FABP4) and demonstration of its association with cardiovascular disease: a path to follow. Nutr. Rev., 2007, 65(3), 130-134.
66. Frayn, K. N.; Fielding, B. A.; Karpe, F. Adipose tissue fatty acid metabolism and cardiovascular disease. Curr. Opin. Lipidol. 2005, 16(4), 409-415.
67. Storch, J.; Thumser, A. E. Tissue-specific functions in the fatty acid-binding protein family. J. Biol. Chem., 2010, 285(43), 32679-32683.
68. Furuhashi, M.; Hotamisligil, G. S. Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets. Nat. Rev. Drug Discov., 2008, 7(6), 489-503.
69. Cernes, R.; Zimlichman, R.; Shargorodsky, M. Arterial elasticity in cardiovascular disease: focus on hypertension, metabolic syndrome and diabetes. Adv. Cardiol., 2008, 45, 65-81.
70. Sa, Q.; Wang, Y.; Li, W. Zhang, L.; Sun, Y. The promoter of an antifungal protein gene from Gastrodia elata confers tissue-specific and fungus-inducible expression patterns and responds to both salicylic acid and jasmonic acid. Plant Cell Rep., 2003, 22(1), 79-84.
71. Liu, W.; Hu, Y. L.; Wang, M.; Xiang, Y.; Hu, Z.; Wang, D. C. Purification, crystallization and preliminary X-ray diffraction analysis of a novel mannose-binding lectin from Gastrodia elata with antifungal properties. Acta Crystallogr. D Biol. Crystallogr., 2002, 58(Pt 10 Pt 2), 1833-1835.
72. Bulpitt, C. J. The uses and misuses of orchids in medicine. Q. J. M., 2005, 98(9), 625-31.
73. Schachter, S. C. Botanicals and herbs: a traditional approach to treating epilepsy. Neurotherapeutics, 2009, 6(2), 415-420.